USA VC Funds

Deep Space Ventures was a Dallas, Texas-based venture capital firm founded in March 2016 by Stephen Hays, a former Wall Street investment banker with over six years of experience in capital raising and M&A advisory. The fund was launched to capitalize on the reallocation of capital from Texas's declining oil and gas sector into a growing technology ecosystem, with a geographic preference for the Dallas-Fort Worth region and a broader national reach. Deep Space invested in seed and Series A stage startups across esports, B2B SaaS, and fintech, with 12 total investments and 10 concentrated in Texas. The firm led rounds and wrote checks in the $500,000 to $1 million range, deploying approximately $1.75 million in its early months across 22 tracked investments. Portfolio companies included Vinli in connected car technology, Panamplify in software analytics, Selery Fulfillment, CounterFind, Legalinc, OpTic Gaming, and Infinite Esports & Entertainment. The fund reported a net IRR of 17.15% and an investment multiple of 3.18x, with a 2.5% management fee and 20% carried interest. Fund operations effectively ceased in August 2018 following the arrest of managing partner Stephen Hays. Hays subsequently founded What If Ventures in January 2020, a separate fund focused on mental health and addiction-related startups. Deep Space Ventures represents a brief but notable chapter in the development of Dallas's early-stage technology investment ecosystem during a period when Texas was diversifying its capital base beyond energy.

DeepWork Capital, established in 2015 and based in Orlando, Florida, is an early-stage venture capital firm. The firm primarily targets technology and life sciences startups, particularly those in U.S. regions traditionally underserved by venture capital. DeepWork Capital's investment strategy focuses on seed and Series A stage companies, often being the first institutional capital after friends, family, and angel investors. Their portfolio includes a diverse range of companies such as AbFero Pharmaceuticals, acquired by Pharmacosmos, and AireHealth, addressing respiratory challenges. Other notable investments include Astrocyte Pharmaceuticals, developing therapeutics for brain injury, and Genascence, working on gene therapy for musculoskeletal diseases. The firm also supports innovative startups like Nanophotonica, which is pioneering EL-QLED technology, and Homee, which digitizes insurance claims processes. The DeepWork Capital team, including Managing Partners Mitchel Laskey, Ben Patz, and Kathy Chiu, brings a wealth of experience from various industries. The firm emphasizes a hands-on, active engagement approach, supporting entrepreneurs before, during, and after investment. DeepWork Capital's mission is to foster innovation in regions like Florida by providing necessary capital and strategic support to tech-forward founders committed to solving significant societal challenges.

Deerfield Management, a prominent investment firm based in New York City, is dedicated to advancing healthcare through strategic investments, information, and philanthropy. With over $14.6 billion in assets under management, Deerfield maintains a diverse portfolio of more than 200 private and public investments across biotechnology, pharmaceuticals, medical devices, healthcare services, and digital health industries​ . Notable portfolio companies include Graphcore, JFrog, and Netskope. The firm has a strong track record of supporting startups from early stages to mature companies, offering flexible funding models, including equity, debt, and joint ventures. Deerfield’s investment approach is characterized by deep operational support and a robust network of strategic partners and academic collaborations​ ​. Deerfield’s team comprises over 150 experienced professionals with expertise in various sectors of healthcare and finance, ensuring comprehensive support for their portfolio companies. The firm’s initiatives, such as the Deerfield Discovery and Development (3DC) and the Cure Campus, further highlight their commitment to fostering innovation and addressing complex health issues​​. The Deerfield Foundation, part of the firm’s philanthropic efforts, focuses on improving healthcare delivery, particularly for underserved populations, and has invested over $68 million in various health initiatives.

Define Ventures is a premier early-stage venture capital firm, singularly focused on investing in digital health companies. With a keen eye for transformative potential, Define Ventures partners with innovative entrepreneurs to reshape the healthcare landscape. Their portfolio features notable investments such as Blackbird Health, which is revolutionizing pediatric mental health, and Lightship, a pioneer in decentralized clinical trials. Define Ventures operates primarily within the digital health sector, focusing on business models that integrate technology and healthcare to create scalable solutions. Geographically, they concentrate their efforts within the United States, fostering close relationships with startups that promise substantial impact in the national healthcare system. The firm’s strategy centers on leading early-stage funding rounds, including incubation, seed, Series A, and Series B stages. Define Ventures is renowned for their hands-on approach, providing not just capital but also strategic guidance and industry expertise to help their portfolio companies thrive. The team is led by industry veterans like Lynne Chou O'Keefe, the founder and managing partner, whose vision drives the firm's success. Other key members include A.G. Breitenstein and Frank Williams, both of whom bring extensive experience in healthcare and digital innovation. Define Ventures has recently closed $460 million across Fund III and an Opportunities Fund, cementing its position as a significant player in digital health investment.

Defy Ventures, a New York-based venture capital firm founded in 2010 by Catherine Hoke, focuses on early-stage investments and supporting entrepreneurs, particularly those with unconventional backgrounds such as former convicts. The firm is dedicated to fostering entrepreneurship, employment, and character training for its community. Defy's portfolio includes notable companies such as Nautilus Biotechnology, Empower, and Shujinko. They have made significant investments in various sectors, including high tech, business services, and food and agriculture tech. Recent investments include Monitaur, Writ, and Delivery Collective. The firm values authenticity and the tenacity needed to transform bold ideas into lasting companies. Defy Ventures aims to be the partner of choice for today's daring startup founders, helping them become tomorrow's visionary leaders. They emphasize working behind the scenes to amplify the success of their portfolio companies.

Dell Technologies Capital (DTC) is the venture capital investment arm of Dell Technologies, focusing on early-stage investments in the enterprise technology space. Since its inception in 2012, DTC has invested in over 150 companies, helping to propel innovations in data and analytics, cybersecurity, infrastructure, developer tools, and silicon. Their notable portfolio includes industry leaders like DocuSign, MongoDB, and Cylance​. DTC’s investment strategy is to partner with founders from the early stages and provide not only capital but also deep domain expertise and operational support. The firm’s extensive network within Dell Technologies offers startups real customer connections and the opportunity to scale with the backing of a tech giant. Investments typically range from seed to growth stages, with DTC often leading the rounds​. Headquartered in Palo Alto, California, DTC’s team of investors, technologists, and operators work closely with portfolio companies, guiding them from inception to market leadership. This hands-on approach ensures that the startups benefit from strategic insights and operational know-how, positioning them for successful exits​​. Overall, Dell Technologies Capital stands out for its commitment to fostering groundbreaking enterprise technologies and its robust support system for startups aiming to disrupt the tech landscape.

Delphi Ventures, founded in 1988, is a venture capital firm based in San Mateo, California. The firm focuses primarily on life sciences, including biotechnology, medical devices, and healthcare IT. Over the years, Delphi Ventures has made significant contributions to the life sciences industry with over 318 investments and 190 exits. Notable investments by Delphi Ventures include Revance Therapeutics, Senseonics, and PTC Therapeutics. These companies have developed innovative solutions in neurotoxin aesthetics, continuous glucose monitoring, and treatments for rare diseases, respectively. Revance Therapeutics, for instance, is now a public company with significant revenue, reflecting Delphi Ventures' ability to identify and nurture high-potential startups. Delphi Ventures' investment strategy is centered on early and growth-stage investments, with a focus on supporting pioneering technologies and therapies. The firm has a strong track record of successful exits, including companies that have gone public such as EBR Systems and Senseonics, as well as several notable acquisitions like Seattle Genetics and Acclarent. The team at Delphi Ventures is led by experienced professionals such as Deepa Pakianathan, Douglas Roeder, and founder James Bochnowski. Their expertise and deep industry knowledge play a critical role in guiding portfolio companies toward successful growth and market leadership.

Dentsu Ventures is the corporate venture capital arm of Dentsu Group, one of the world's largest advertising and marketing conglomerates. Founded in April 2015 and headquartered in Tokyo, Japan, the firm operates two funds totaling 20 billion yen (approximately $134 million): Global Fund I covering 2015 to 2025 and Fund II launched in 2021 with a ten-year life. Managing Partner Kotaro Sasamoto leads a team that includes General Partners Daiji Horibe, Kevin Hasegawa, and Daisuke Takemori. With 65 investments across the US, Europe, and Asia-Pacific, Dentsu Ventures backs companies from Seed through late stage in AI, advertising and marketing technology, media and entertainment, biotech, data analytics, and VR/AR. The portfolio has produced three unicorns, two IPOs, and 12 acquisitions. Notable investments include Mysten Labs (blockchain), GRAIL (cancer detection, acquired by Illumina), Twist Bioscience (synthetic biology, IPO), Kognitos (enterprise AI automation), and Skyflow (data privacy). Dentsu Ventures differentiates from independent VCs by offering portfolio companies direct access to Dentsu Group's global marketing capabilities, client relationships, and co-creation resources. Startups gain the dual benefit of financial backing and commercial acceleration through one of the world's most extensive advertising networks, making the firm particularly valuable to companies building in consumer-facing and enterprise software categories.

Designer Fund is a San Francisco-based venture capital firm founded by Ben Blumenrose and Enrique Allen, specializing in seed-stage investments in design-led startups. Notable investments include Omada Health, Gusto, and Stripe, companies recognized for their innovative design approaches and user-friendly interfaces. The fund primarily targets industries like financial services, healthcare, and sustainability, aiming to replace legacy systems with more efficient, user-centered solutions. Designer Fund focuses geographically on the US, with a strong presence in the Bay Area. Their strategy involves making significant contributions to seed rounds, typically around $500,000, while often not leading. They invest in about eight companies annually, allowing them to provide extensive design support through their Designer Fund Partnership. This support includes monthly design sessions, professional development workshops, and access to a community of top designers and founders. The team at Designer Fund is led by seasoned experts like Blumenrose, with extensive experience at Meta, and Allen, who has a background with Facebook’s fbFund and 500 Startups. Their collaborative approach and deep integration within the design community make them a valuable partner for startups aiming to scale their design capabilities and impact.

Beyond1435 is Deutsche Bahn's venture capital initiative that focuses on fostering innovation in the transportation and mobility sectors. Emerging from DB Digital Ventures in 2016, Beyond1435 has established itself as a key player in driving the future of rail and mobility technologies. The platform is dedicated to identifying and investing in early-stage startups that offer transformative solutions in areas like sustainability, production, and digital services. The firm partners with startups to develop technologies that align with Deutsche Bahn’s long-term goals of modernizing rail transport and enhancing operational efficiency. Beyond1435 supports startups through investment, collaboration, and access to Deutsche Bahn’s extensive global network. The firm focuses on technologies related to artificial intelligence, IoT, mobility, and smart cities. By fostering collaborations with external companies and setting up joint ventures, Beyond1435 strengthens not only Deutsche Bahn but also the wider mobility ecosystem. Its broad portfolio includes companies such as Brighter AI, Gideon Brothers, and Skyports, reflecting its commitment to advancing innovative technologies across sectors.

Deutsche Bank Corporate Venture Capital (CVC) is the global corporate venture program of Deutsche Bank AG, one of the world's leading financial institutions. Launched in 2020 with offices in Frankfurt, New York, and Berlin, the program is led by Jörg Landsch — Head of Central Corporate Venture Capital and a Deutsche Bank veteran since 2001 — alongside team member Milos Spiridnovic. The CVC takes strategic minority positions in early growth-stage companies, with average checks between $1 million and $10 million. With 44 investments and 12 exits to date, the portfolio concentrates on fintech, AI, ESG technology, cybersecurity, and cloud software. Notable portfolio companies include Deel (global HR and payroll platform), Kodex AI (financial data analytics), Plan A (carbon accounting), Akeyless (identity security), Axoni (distributed ledger infrastructure for capital markets), and Binalyze (digital forensics). Deutsche Bank is also an LP in High-Tech Gründerfonds, the German seed-stage fund. The CVC's investment thesis is explicitly strategic: Deutsche Bank targets companies that use technology to support or enable banking and financial services, as well as broader enterprise technology. AI and ESG are the two largest priority areas. The program partners with innovative startups to shape the future of financial services, giving portfolio companies access to Deutsche Bank's global client relationships and regulatory expertise alongside the capital investment.

DTCP (Digital Transformation Capital Partners) is an independent investment management firm founded in 2015. The firm focuses on two main investment strategies: Growth Equity and Digital Infrastructure. With over €2.2 billion in assets under management, DTCP has invested in more than 60 companies, supporting transformative technology leaders globally and digital infrastructure projects in Europe. DTCP's Growth Equity platform targets technology sectors such as cybersecurity, AI, fintech, and cloud-based enterprise software, aiming to accelerate digital transformation. Their notable portfolio includes investments in companies like Aryaka, NS1, and Heap. The firm’s data-driven investment approach and strong operational support help these companies scale effectively. In the Digital Infrastructure space, DTCP invests in mobile towers, fiber networks, and data centers. Key infrastructure investments include Swiss Towers, Community Fibre Limited, and Cellnex Netherlands. This strategy focuses on creating long-term value and supporting sustainable digital infrastructure development across Europe. The leadership team is headed by CEO Vicente Vento and includes Managing Partner Jack Young, who oversees the Growth platform, and Philipp von Bismarck, Managing Partner for the Digital Infrastructure Vehicle II. They bring extensive experience in technology investments and digital infrastructure projects. DTCP’s approach combines strategic capital investment with operational expertise, leveraging a strong network of industry relationships to drive growth and innovation in its portfolio companies.

Devlabs is a micro venture capital firm with a focus on early-stage investments in North America, South America, and the Caribbean. Established in 2013 and headquartered in Oakland, California, and Temuco, Chile, Devlabs manages an $8 million fund dedicated to pre-seed investments in software startups, with plans to close a $21 million fund for agriculture and renewable energy sectors​. The firm typically invests between $100,000 and $300,000 per company in exchange for 5-15% equity, targeting industries such as B2B software in agri-business, finance, health, tourism, education, and operations​. Devlabs focuses on high-impact, high-growth tech entrepreneurs, especially those addressing multi-billion dollar problems with market-driven solutions. Devlabs was co-founded by Jose D Lopez and Ruben Hernandez, both of whom bring over 20 years of experience in venture capital, software development, and business innovation​ (devlabs)​. The firm leverages its extensive network and experience in emerging markets to reduce barriers and costs for investment, aiming to support lean, early-stage companies and help them scale rapidly.

Dexcel Pharma is the largest private pharmaceutical company in Israel, renowned for its extensive portfolio of branded and generic drugs. Founded in 1968, the company has grown into a global player, with state-of-the-art R&D and manufacturing facilities that support the development and commercialization of innovative and cost-effective pharmaceutical products. Dexcel's product portfolio spans across various therapeutic areas, including small molecules, biologics, and RNA-based therapies. The company is committed to advancing science through substantial investments in R&D, particularly in cutting-edge fields like siRNA therapeutics and oligonucleotides. Their innovation initiatives include the creation of specialized entities like Dexoligo Therapeutics, which focuses on RNA-based medicines, and Clexio Biosciences, which develops treatments for neurological and psychiatric conditions. With over 1,200 employees and a strong presence in key markets like the United States, Germany, and the UK, Dexcel manufactures over 5 billion oral-solid dosages annually. The company maintains a reputation for quality, with its facilities meeting global standards and holding approvals from regulatory bodies like the FDA and EMA.

DG Ventures (formerly DG Incubation) is the corporate venture capital arm of Digital Garage, Inc. (TSE: 4819), with dual headquarters in San Francisco and Tokyo. Founded in 2009, the firm manages approximately $600 million in assets under management, with geographic allocation across the United States (54%), Asia and India (21%), and Japan (10%), complemented by a global fund-of-funds strategy. The 14-person team, including six partners, is led by Kaoru Hayashi — co-founder of Digital Garage in 1995 — and Keith Yuki Isobe as Founder and Managing Director. DG Ventures leads rounds and has made 335 investments with an extraordinary exit record: 11 unicorns, 17 IPOs, and 39 acquisitions. The portfolio includes Twitter (pre-IPO), LinkedIn, Facebook, Coinbase, Airbnb, Twilio, GrubHub, Udemy, ThredUp, Intercom, Lime, GoJek, and MystenLabs. The firm invests from seed through late stage across fintech, AI, blockchain, SaaS, e-commerce, proptech, mobility, healthcare, and marketplace sectors. DG Ventures also co-manages DG Lab Fund II (approximately JPY 12.5 billion) with DG Daiwa Ventures targeting next-generation technology startups, and operates GenLab, a startup studio for generative AI entrepreneurs. The combination of a seasoned institutional track record, deep Japanese corporate relationships, and active US presence gives DG Ventures a distinctive cross-Pacific vantage point across its investment activity.

DGNL Ventures is an early-stage venture capital fund founded in 2016 by Desiree Gruber and Nir Liberboim, headquartered in New York City. The firm invests exclusively in the consumer sector, making minority investments in high-growth companies across consumer technology, consumer goods, and consumer media. DGNL targets post-revenue companies with at least $1 million in sales, demonstrated product-market fit, retail distribution, and strong founding teams. Gruber also serves as CEO of Full Picture, a media and entertainment firm, giving the partnership direct industry relationships. With 27 investments to date, DGNL writes checks between $500,000 and $3 million at Seed and Series A stages. The portfolio spans food and beverage (Banza, Magic Spoon, Icelandic Provisions, Just Water), beauty and personal care (Fekkai, Moon Juice, Wander Beauty), health and wellness (Maven Clinic, Ladder, The Well), fashion (Sarah Flint), and consumer technology (Quip). Maven Clinic reached unicorn status in 2021, and the portfolio has generated nine acquisitions including Sir Kensington's and Brava Home. DGNL's investment philosophy centers on backing distinctive brands founded by differentiated operators who are disrupting traditional categories with new business models. The firm looks for founders who understand both the product and the consumer deeply, then applies its media and entertainment relationships to accelerate brand reach and retail distribution — a value-add that extends well beyond the initial check.

DHVC, founded in 2013 by Shoucheng Zhang, is a venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments across several sectors, including enterprise, consumer, fintech, and healthcare. Over the years, DHVC has built a substantial portfolio, investing in over 267 companies with 75 successful exits​. DHVC has also seen significant exits with companies like Wish Shopping, Qeexo, and Namocell, indicating their strong presence in the tech investment space. The firm’s investment strategy involves participating in a mix of seed, early-stage, and later-stage funding rounds, often co-investing with other prominent venture capital firms​. The DHVC team, led by key members such as Kevin Ding and Judy Yan, brings a wealth of experience and a global perspective to their investment approach. The firm’s operations are split between the United States and China, allowing them to leverage opportunities across major innovation hubs​.

Diageo is a global leader in the beverage alcohol industry, headquartered in London, UK. Established in 1997 through the merger of Guinness PLC and Grand Metropolitan, the company has grown into a powerhouse, owning a vast portfolio of iconic brands across spirits, beer, and wine. Its flagship brands include Johnnie Walker, Guinness, Tanqueray, Smirnoff, and Baileys, which are enjoyed in over 180 countries. Diageo's business model focuses on premiumization, innovation, and sustainability. It operates in three major regions: North America, Europe, and Asia-Pacific, with North America being its largest market. The company continuously invests in expanding its product lines, with a particular emphasis on premium and ultra-premium categories. In recent years, Diageo has strengthened its position in the tequila market with brands like Don Julio and Casamigos. Sustainability and social responsibility are core to Diageo’s operations. The company is committed to reducing carbon emissions, water usage, and plastic waste across its production facilities, with ambitious goals set for 2030. Additionally, Diageo has a long history of promoting responsible drinking through campaigns and partnerships worldwide. Led by CEO Ivan Menezes, Diageo continues to focus on long-term growth by exploring new markets, embracing digital innovation, and investing in a diversified portfolio of brands that cater to evolving consumer preferences. The company’s strategy combines its rich heritage with forward-thinking initiatives, solidifying its position as a global leader in the spirits industry.

Diagram is a venture capital firm and venture builder based in Montreal and Toronto, with over $350 million in assets under management. Launched in 2016, Diagram focuses on Fintech, Web3, and ClimateTech industries. It stands out for its hands-on approach, where it not only provides capital but also actively collaborates with founders to build and launch companies. Since its inception, Diagram has helped launch over 20 ventures, raising more than $500 million across its portfolio, and creating substantial shareholder value. The firm's investment model centers on early-stage companies, providing founders with access to its extensive global network of investors, operators, and industry leaders. This helps accelerate the growth and success of its portfolio companies. Notable investments in Diagram's portfolio include companies like WorkOS, Weights & Biases, and CitadelID. Diagram combines its venture building expertise with strategic investments, making it a strong player in supporting companies from idea to execution in their respective markets​.

DIC Corporation operates a Corporate Venture Capital (CVC) unit that focuses on strategic investments aligned with their core mission of sustainable innovation. Founded as a global leader in fine chemicals, DIC leverages its venture capital arm to support startups that bring new, disruptive technologies in areas like biomanufacturing, advanced materials, and industrial IT. Their investment strategy aims to complement their existing businesses in sectors such as color science, healthcare, and packaging. Recent notable investments include funding Debut Biotechnology, a California-based company specializing in sustainable biomanufacturing. This partnership allows DIC to accelerate the development of bio-based materials, particularly natural pigments for cosmetics and nutrition, aligning with their long-term vision of sustainability under the DIC Vision 2030 plan. DIC's CVC activities also extend to partnerships with other venture funds, such as their collaboration with Emerald Technology Ventures, which focuses on industrial innovation in clean technology. DIC’s strategic approach to venture investing helps them explore new markets while enhancing their capabilities in sustainable products, driving innovation across their global network of over 190 companies.

Differential Ventures is a seed-stage venture capital fund founded by data scientists and entrepreneurs, with a focus on investing in B2B, data-centric technology startups. Notable investments include companies like Private AI, Ocrolus, and Agnostiq, which are at the forefront of AI, machine learning, and quantum computing. The fund primarily targets enterprises that leverage data to transform business operations, with significant investments in AI-powered business solutions, cybersecurity, and fintech. Geographically, Differential Ventures is based in New York but maintains a broad investment horizon, with portfolio companies spread across North America. Their strategy emphasizes early-stage investments, typically writing checks between $250,000 and $1 million, and they often lead funding rounds. The firm is proactive in offering guidance to portfolio companies, drawing on their deep expertise in data science and entrepreneurial ventures. Key team members include Nick Adams, co-founder and managing partner, known for his hands-on approach and operational insights, and David Magerman, a managing partner who brings extensive experience in AI and machine learning operations. Differential Ventures is known for its active involvement in the tech community, hosting webinars and engaging in discussions about AI policy and its implications for industry and society. For startups seeking investment, approaching Differential Ventures with a well-defined data-driven strategy and a scalable business model is crucial.

DIG Ventures is a London-based early-stage venture capital firm founded in 2018 by Ross Mason — founder of MuleSoft, acquired by Salesforce for $6.5 billion — and Melissa Klinger, former UK sales lead at MuleSoft. The firm invests at pre-seed and seed stages in B2B SaaS, AI, and cloud infrastructure companies across Europe, Israel, and the US. In April 2025, DIG closed its first institutional fund (Fund II) at €90 million, backed by The Hillman Company, Granite Capital, Sofina, and Grove Street. DIG leads rounds across a portfolio of 41-plus companies with four exits, including Makerpad (to Zapier) and Otterize. The portfolio includes unicorns People.ai and Karat, alongside Bubble, ComplyAdvantage, PlanetScale, Rasa, Taktile, Rossum, Flock, and Prophecy. Partner Rytis Vitkauskas — founder of YPlan and former Lightspeed partner — has backed seven unicorns including Personio, Matillion, and Nord Security. Portfolio companies achieve an 80% follow-on funding success rate within two years of DIG's initial investment. DIG positions itself as a founders' fund: the partners invest early — often with just a deck and a vision — and actively support Europe-to-US expansion from direct personal experience doing exactly that with MuleSoft. Operational depth in building, scaling, and exiting B2B software businesses is the core value-add the firm brings beyond capital.

Digital Currency Group (DCG), founded in 2015 by Barry Silbert, is a prominent venture capital firm dedicated to accelerating the development of a better financial system through investments in blockchain and digital currency companies. With over 200 equity investments in more than 30 countries, DCG has established itself as the most active investor in the digital asset industry. DCG owns and operates several leading businesses within the crypto ecosystem. These include CoinDesk, a top media, research, and events platform; Genesis, a major institutional lending and brokerage firm; Grayscale Investments, the largest digital currency asset management firm; Foundry, which focuses on digital asset mining and staking; and Luno, a global digital asset exchange and wallet provider​. Their investment strategy encompasses a broad array of sectors such as payments, privacy, stablecoins, trading tools, Web3 infrastructure, DeFi, and NFTs, among others. DCG supports companies at various stages of development, from seed and venture to growth and public markets, ensuring comprehensive support through all phases of their growth​.

Digital Leaders Ventures (DLV) is a European venture capital fund founded in 2014 and headquartered in Luxembourg, operating as a fully registered alternative investment fund manager and AIF. The firm was founded by Monty C. M. Metzger, a serial entrepreneur and digital futurist, and Thomas S. Enge, a financial executive and former CFO at simyo and amaysim. DLV invests through its Ignition Fund in fast-growth tech companies with scalable business models, targeting startups that have working products, early customers, and initial revenues — typically post-accelerator or post-seed stage. With 8 investments to date, DLV writes checks of $100,000 to $1 million at Seed and Series A. The fund focuses on six key sectors: Smart Cities, Education, Healthcare, Finance including blockchain, Communication, and Mobility and Industry 4.0. Portfolio companies include Aircall (cloud-based phone systems), PayKey (mobile banking via social keyboards), Cortrium (cardiac monitoring), Revue (newsletter platform acquired by Twitter), and VOIQ. Co-investors have included Balderton Capital, Greylock Partners, Y Combinator, and 500 Startups. DLV leverages its global network through DigitalLeaders.co to support founders scaling internationally, with portfolio companies headquartered across the USA, Israel, Denmark, France, and the UK. The firm also maintains a syndicate on AngelList, broadening its deal access and co-investment capacity across the European and global tech landscape.

Digital News Ventures was an early-stage investment fund operated by MDIF (Media Development Investment Fund), a New York-based not-for-profit corporation founded in 1995 by Saša Vučinić and the late Washington Post editor Stuart Auerbach. Active from 2012 to 2015, the fund deployed $3.8 million in early-stage digital news and information businesses, with checks ranging from $30,000 to $300,000 at pre-seed and seed stages. MDIF overall managed $119.1 million in assets across 62 media businesses in 35 countries before winding down in June 2025. With 9 investments recorded, the portfolio includes Mic (US digital news platform with 20 million monthly users), Malaysiakini (leading Malaysian political news site), Katadata (Indonesian business news), Colab.re (Brazilian civic engagement platform), Gram Vaani (Indian voice-based social media), Rock Content (Brazilian content marketing), and Dataphyte (Nigerian data analytics). The fund was subsequently succeeded by MDIF Ventures, which continued the mission with approximately $2 million deployed across nine early-stage companies in seven countries. The fund's founding thesis was that independent journalism requires dedicated capital in markets where free press is under threat. CEO Harlan Mandel (since 2011) and Managing Director of Media Programs Bilal Randeree directed investments toward entrepreneurs building platforms, tools, and services that make digital-age news businesses commercially viable, with a geographic emphasis on Southeast Asia, Latin America, Africa, and India. The fund is now permanently closed.

DigitalDx Ventures is a majority women-owned, early-stage venture capital fund founded in 2018 and headquartered in Menlo Park, California. Founded and led by Michele Colucci, the firm invests in health technology companies that use artificial intelligence and big data to transform diagnostics and therapeutics. Target areas include breast and other cancers, cardiovascular and kidney health, Alzheimer's disease, and mental health diagnostics. The fund has raised two funds with combined AUM under $25 million. With 8 investments to date, DigitalDx leads rounds at pre-seed through Series A stages with average checks of approximately $1.5 million. Portfolio companies include NOWDiagnostics (for which the firm led a $22.5 million Series B), Oxford Cancer Analytics, and GLX Analytix. Over 50% of portfolio companies feature women founders or C-suite executives. The investment team — including partners Eric Weiss, Vanessa Small, Melody Po, Sharad Mishra, and Erin Niehaus — applies a proprietary evaluation model called iTED (Investment Tool for Expert Diagnostics) that weighs team diversity, problem scale, and solution invasiveness. DigitalDx maintains a robust Experts and Entrepreneurs in Residence program with 24-plus distinguished operators from medicine, engineering, finance, law, and pharma, alongside a fellowship program that has enrolled more than 100 participants from top global universities. The firm's scientific advisory board includes Nobel Prize-winning scientists and Fortune 100 executives, giving portfolio companies access to clinical and commercial validation well beyond what the fund size alone would suggest.

Digitalis Ventures is a venture capital firm established in 2016, focused on investing in innovative solutions within the realms of human and animal health. Headquartered in New York, with offices in Boston, Los Angeles, San Diego, San Francisco, and Gainesville, the firm leverages deep technical, financial, and domain expertise to support early-stage companies. Digitalis Ventures’ portfolio includes companies like Expressable, Elegen, and Alterome Therapeutics, reflecting their interest in biotechnology, health technologies, and services. Notable exits include Scout Bio and PetMedix. The firm typically leads investment rounds, providing substantial capital and strategic guidance to help startups scale. The investment strategy centers around life sciences, health technologies, and animal health. They invest in companies developing breakthrough technologies in therapeutics, diagnostics, and tools that improve healthcare access, outcomes, and efficiency. Their Companion Fund specifically focuses on advancing animal health. Key team members include founder Geoffrey Smith and partners such as Amit Bansal and Drew Taylor, who bring extensive experience in venture investing and health technologies.

firm focuses on investing in early-stage companies within the digital health sector, aiming to address significant challenges and inefficiencies in healthcare. Their investment strategy centers on data-driven technologies that can revolutionize healthcare and improve patient outcomes through innovative solutions in personalized medicine, data analytics, and digital therapeutics. DigiTx Partners is notable for backing companies like Eko, which develops diagnostic devices for heart and lung diseases, and Rune Labs, which focuses on precision neurology through software and data analytics. Their portfolio also includes Cleerly, specializing in cardiovascular disease diagnostics, and Savonix, which offers cognitive function management systems. The firm was created as a joint venture between Astellas Pharma and MPM Capital, and it raised $75 million for its Rx Digital Fund in 2018. This fund supports seed and Series A-stage companies that are developing healthcare and life sciences technology utilizing data​. Key team members include Managing Director David Kim, MD, and Partner & Principal Miraj Sanghvi, who bring substantial expertise in healthcare and investment management.

Dimension Capital is an early-stage venture capital firm founded in 2022 by industry veterans from Lux Capital and Obvious Ventures. With a focus on the intersection of biotechnology, life sciences, and technology, the firm operates a $350 million fund aimed at digitizing the biotech sector. Their mission is to break down the traditional silos separating technology and life sciences, creating new synergies between fields like drug discovery and artificial intelligence. Dimension invests in startups that leverage technology to drive advancements in biotech, such as Enveda Biosciences and Kaleidoscope Bio. The firm targets transformative companies in sectors including AI-driven drug discovery, machine learning applications in healthcare, and advanced manufacturing. Led by Adam Goulburn, Zavain Dar, and Nan Li, Dimension emphasizes long-term partnerships with founders, providing both capital and strategic guidance. They are particularly interested in companies at the forefront of merging biology with computational technologies, a space they believe is critical to the future of medicine​. Based in New York and San Francisco, Dimension is well-positioned in two key innovation hubs, giving it access to cutting-edge talent and startups that are redefining the biotech landscape​.

Disruption Ventures is a private, female-founded venture capital firm based in Toronto, Canada, founded in 2018 by Elaine Kunda. The firm invests exclusively in companies founded and led by women, targeting North American high-growth startups at the Seed stage with a target fund size of $30 million. Scotiabank is a notable LP, and the firm is a member of Beyond The Billion, a global consortium channeling capital to women-led funds. The team includes General Partner Elaine Kunda, Partner Eugene Bomba (a CPA with CFO experience at ThoughtWire), and Principal Sarah Shapiro. Disruption Ventures leads rounds and writes checks averaging $750,000, investing across B2B SaaS, health tech, e-commerce, edtech, fintech, and AI. The portfolio spans eight investments in two funds. Fund I companies include PracticeBetter (health and wellness practice management SaaS), Hostfully (vacation rental property management), MakerKids (coding and robotics education), Fable (digital accessibility testing, exited), and ePACT (emergency management SaaS, exited November 2022). Fund II investments include Blanka (beauty e-commerce drop-shipping), Ginger Desk (virtual medical office assistants), and Vee (AI platform for nonprofits). The firm emphasizes operational support alongside capital, applying data-driven metrics analysis and a strong advisor network to help portfolio companies scale. By focusing exclusively on women founders, Disruption Ventures addresses a persistent gap in the Canadian venture market, where female-led startups have historically received a disproportionately small share of venture investment.

Distill Ventures is a London-based drinks industry accelerator and venture fund founded in 2013 by Shilen Patel and Frank Lampen, backed by Diageo, the world's largest premium spirits company. Over its decade of operation, Distill deployed approximately £245 million and funded 35-plus startups across alcoholic and non-alcoholic categories — from early-stage brand development through growth-stage investment. CEO Heidi Dillon leads the firm. Investment sizes ranged from £250,000 to over £10 million, and the firm leads rounds in its portfolio companies. The partnership model was designed with a clear exit logic: Diageo funded startups while Distill provided hands-on brand-building expertise, with acquisitions as the intended outcome for successful graduates. Notable exits bear this out — Seedlip (pioneering non-alcoholic spirits, acquired 2019), Kikori (Japanese rice whiskey, 2018), Belsazar (German vermouth, 2018), Mr Black (Australian cold brew coffee liqueur, 2022), and Ritual Zero Proof (acquired 2024). The current portfolio includes whisky brands Starward, Westward Whiskey, Stauning Whisky, Kanosuke, and Fielden Whisky. In 2021, Distill launched a Pre-Accelerator program committing more than $10 million to entrepreneurs from underrepresented communities. In March 2025, Diageo announced it would no longer bring new brands into the program, effectively winding down new investment activity. A smaller team continues managing existing portfolio investments, ensuring brands that graduated from the program receive ongoing support through their development.

Distributed Ventures is a venture capital firm that focuses on investing in startups transforming the future of risk management across sectors like Insurtech, Fintech, and Health & Benefits. Originally incubated within NFP Ventures, the firm spun out as an independent entity in 2021 to focus on supporting early-stage companies. Distributed Ventures typically invests in late seed and Series A rounds, with a strong emphasis on businesses that drive innovation in their respective fields. The firm’s investment approach is rooted in its deep industry expertise, combining financial backing with strategic guidance to help portfolio companies scale efficiently. Distributed Ventures is particularly known for its hands-on involvement, offering operational support through its team of experienced investors and operators. The firm’s portfolio includes a diverse array of startups, such as those improving healthcare delivery, enhancing financial services, and innovating within the insurance industry. This focus on sectors at the intersection of technology and risk management reflects Distributed Ventures' commitment to shaping the future of these critical industries. The firm is led by a seasoned team, including Managing Partner Shawn Ellis, who has a strong background in venture capital and corporate innovation. Distributed Ventures is also notable for its strategic partnerships, which enable the firm to provide more than just capital to its portfolio companies, helping them navigate complex regulatory landscapes and scale their operations effectively​.

District Ventures Capital is a Calgary-based venture capital fund founded in 2016 by Arlene Dickinson, the renowned Canadian entrepreneur and long-time Dragons' Den star. The firm specializes in consumer packaged goods (CPG) companies in food and beverage and health and wellness sectors across Canada and the US. Fund I closed at $100 million in September 2019 with institutional LPs including OMERS ($33 million), BMO, Farm Credit Canada, and BDC Capital. Fund II has followed with Export Development Canada (EDC) as a committing LP. With 48 investments to date, District leads rounds with typical checks in the $500,000 to $5 million range. Portfolio companies include Just Vertical (hydroponic growing systems), Three Farmers (roasted bean snacks), and Vertiball (muscular care device). The firm's largest investment to date is a $20 million deal in Huha Wear Inc. (women's intimate apparel), co-invested with EDC in November 2025 — the largest investment in Dragons' Den's 20-year history, originating from Season 18. Partner and CFO Jason Berenstein oversees transaction origination, due diligence, and fund operations. District also operates Venturepark Labs, an accelerator program investing $150,000 per startup in semi-annual cohorts, giving the firm a built-in pipeline of early-stage consumer brands. The combination of Dickinson's public profile, institutional LP base, and operating accelerator makes District well-positioned to identify and accelerate emerging CPG brands before they reach broad retail distribution.

Divergent Capital is a New York-based venture capital firm founded in 2020 by Katie Shea and Lucy Wang. The fund focuses on pre-seed investments, typically writing checks between $250,000 and $750,000. Divergent Capital aims to back 20-25 companies, emphasizing high-conviction investments with deep engagement in sectors like AI, machine learning, robotics, biotech, logistics, and digital health. The firm is known for investing in founders with innovative technologies and unique customer insights, often those outside the traditional Silicon Valley circles. Divergent takes a hands-on approach with its portfolio companies, offering strategic guidance on product development, go-to-market strategies, and scaling. They prefer working with founders who have a deep personal connection to the problem they are solving, focusing on practical, product-driven growth rather than market size alone. Notable investments include companies like Hoop, Motif Neurotech, and Ceragen, spanning industries from productivity software to biotechnology.

Divergent Capital is a venture capital firm based in San Francisco, specializing in early-stage investments in innovative technology sectors. Founded by Katie Shea and Christophe Goffoz, the firm manages a diverse portfolio of companies that are making significant advancements in their respective fields. Notable investments by Divergent Capital include Justpoint, which uses AI to enhance patient advocacy in healthcare, and Motif Neurotech, a company developing cutting-edge neurotechnology for mental health treatments. The firm has also invested in Harmony Baby Nutrition, which focuses on nutritious baby food, and Bedrock Energy, which is working on sustainable energy solutions. Divergent Capital is committed to supporting transformative technologies that have the potential for substantial social and environmental impact. The firm’s strategy includes providing not only capital but also strategic guidance and resources to help startups succeed and scale effectively. This approach underscores their mission to drive meaningful innovation and positive change through their investments.

dmg ventures is the corporate venture capital arm of Daily Mail and General Trust plc (DMGT), launched in 2018 and headquartered in London. The firm leverages DMGT's media properties — including the Daily Mail, MailOnline, The Metro, and The i newspaper — reaching more than 155 million global monthly consumers to help portfolio companies achieve consumer scale. The team of seven is led by CEO and Co-Founder Manuel Lopo de Carvalho, alongside partners Rachel Muzyczka and Taos Edmondson. The firm operates two funds totaling £50 million: the Headline Fund (£25 million) investing £250,000 to £1.5 million at Seed to Series A, and the Scale Fund (£25 million) providing £1 million to £5 million primarily through media-for-equity deals at Series B and beyond. The portfolio of 34 companies includes one unicorn (Zilch, a BNPL fintech), two IPOs (Taboola on NASDAQ, Cazoo on NYSE), and six acquisitions including Farewill (acquired by Dignity). Additional investments include Impossible Foods, Lucky Energy, and Final Boss Sour. The firm's distinctive model blends cash investment with discounted media credits, giving portfolio companies guaranteed sponsored content opportunities across DMGT's publications. This combination of capital and commercial media reach is particularly effective for consumer, retail, fintech, and food and beverage brands that need to build mass awareness cost-efficiently. Geographic focus spans the UK, US, and Western Europe.

DN Capital, founded in 2000, is a global early-stage venture capital firm with offices in London, Berlin, and San Francisco. They focus on Seed, Series A, and select Series B opportunities across Europe and North America. The firm specializes in sectors such as fintech, SaaS, digital media, marketplaces, and consumer internet. Some of DN Capital's notable investments include Shazam, Auto1, OLX, Purplebricks, and GoStudent. These investments showcase DN Capital's knack for identifying and supporting companies that can scale globally. They have managed over $1 billion in assets and achieved numerous successful exits, including acquisitions by major corporations such as Apple (Shazam) and Oracle (Endeca)​. The firm is led by founders Nenad Marovac and Steve Schlenker, who bring deep entrepreneurial and financial expertise. DN Capital emphasizes a hands-on approach, providing portfolio companies with strategic guidance, business development opportunities, and extensive network connections. Their commitment to openness and integrity, combined with rigorous investment practices, makes them a strong partner for ambitious entrepreneurs

DNS Capital is the investment office for Gigi Pritzker and her husband Michael Pucker, based in Chicago. Founded in 2014, DNS Capital invests across various stages and industries, emphasizing long-term partnerships and strategic growth. The firm has a diverse portfolio with significant investments in technology, healthcare, and industrial sectors. Notable investments include Hero Bread, which focuses on producing low-carb bakery products; IMIDomics, a biotech company working on therapeutics for immune-mediated inflammatory diseases; and Jetti Resources, which has developed a novel technology for metal extraction from ores. Other key investments include Recogni, a company specializing in high-performance computer chips for autonomous vehicles, and PayNearMe, a platform enhancing payment experiences for businesses and their customers​​. DNS Capital's approach combines financial support with strategic guidance, leveraging the deep expertise of its leadership team. They focus on building strong relationships with business owners and management teams to drive sustainable growth and innovation across their portfolio companies​.

DNV (formerly DNV GL) is a global leader in quality assurance and risk management, with roots tracing back to 1864. Headquartered in Norway, the company provides a wide range of services across various industries, including maritime, oil and gas, renewable energy, and healthcare. DNV focuses on enhancing safety, efficiency, and sustainability through its services, which include classification, technical assurance, certification, and advisory. In 2021, DNV rebranded from DNV GL, reflecting its streamlined strategy for the future. The company is organized into six main business areas: Maritime, Energy Systems, Business Assurance, Supply Chain & Product Assurance, Digital Solutions, and the Accelerator, which fosters growth through acquisitions and partnerships. DNV invests heavily in research and development, dedicating about 5% of its annual revenue to innovation. This commitment is evident in its work on projects related to the energy transition, digital assurance, and artificial intelligence, aiming to set new global standards in these areas. The company’s recent acquisitions, such as Nixu, a cybersecurity firm, and ANB Systems, a SaaS provider for energy programs, highlight DNV’s strategic expansion into critical sectors like cybersecurity and digital transformation. DNV is owned by Stiftelsen Det Norske Veritas, a foundation with the mission of safeguarding life, property, and the environment. This ownership structure supports DNV’s long-term vision and commitment to sustainability, as all profits are reinvested into the company to further its mission​.

DNX Ventures is an early-stage venture capital firm specializing in B2B startups, with a particular focus on SaaS, cybersecurity, fintech, deep tech, sustainability, and retail tech sectors. Founded in 2011, DNX Ventures operates from offices in Silicon Valley and Tokyo, bridging two of the world's most innovative markets. The firm invests in seed and Series A startups, typically providing initial investments ranging from $1 to $5 million. DNX Ventures aims to support founders who are tackling significant challenges for enterprise companies, helping them shape industries and transform the way we live and work. Notable investments by DNX Ventures include Cylance, ICEYE, Movandi, and Nauto. Their approach emphasizes close partnership with portfolio companies, offering extensive support and resources to help them succeed.

DO Venture Partners is a women-founded early-stage venture capital firm based in San Francisco, founded in 2016 by Duygu Oktem Clark and Ed van Puffelen. The firm invests in mission-driven founders building early-stage tech startups in Silicon Valley by partnering with European VC funds. Founding Managing Partner Duygu Oktem Clark is a computer engineer with a master's in information systems and 15-plus years in technology as both an operator and investor. She previously led R&D teams at Turk Telekom Group overseeing 40-plus innovation projects with a combined $100 million-plus budget, founded Turkey's first startup accelerator, led eight investments at the European Investment Fund, and serves as a startup evaluator for the European Commission's Innovation Council. DO Venture Partners has deployed $4 million across 14 portfolio companies, writing checks of $50,000 to $100,000 and making six to ten investments per year. Focus sectors include AI, fintech, developer tools, remote working tools, sustainable technologies, and B2B SaaS. Portfolio companies include dahmakan (AI food delivery and logistics), CoScreen (acquired by Datadog), Legalpad (acquired), and SEED (acquired). Three exits via acquisition have been completed. Clark places team quality at the center of investment decisions — approximately 80% of her assessment — and backs founders who are singularly focused on solving well-defined problems. The firm's dual footing in Silicon Valley and European VC networks gives it a distinctive vantage point for bridging cross-Atlantic deal flow and co-investment relationships.

Dolby Family Ventures is a San Francisco-based venture capital firm founded in 2014 by David Dolby, investing in early-stage companies tackling frontier science and engineering challenges. Unaffiliated with Dolby Laboratories, the firm manages approximately $196 million in assets under management. The 16-person team is led by David Dolby as CEO, Senior Managing Director Pascal Levensohn, and Managing Director Andrew Krowne, supported by a distinguished Scientific Advisory Board. With 106 investments and a strong exit track record of 6 IPOs and 17 acquisitions, Dolby Family Ventures leads rounds across pre-seed, seed, and Series A with checks from $1 million to $25 million. The five core verticals are precision neuroscience (neurodegeneration, psychiatry, neurotech), life sciences platforms (regenerative medicine, computational biology), climate tech, aerospace, and digital deep tech. Portfolio companies include Motif Neurotech, Therini Bio, Ursa Major Technologies, Twelve, Paradromics, Bionaut Labs, and DigiLens. IPO exits include Athira Pharma, Eargo, Cognition Therapeutics, and Tempo Automation; acquisition exits include August (by Assa Abloy), Wickr (by Amazon), and Eyefluence (by Google). The firm takes a long-term collaborative approach, partnering with best-in-class innovators and syndicate partners to build transformative technology companies. Its willingness to back science-forward ventures at the earliest stages — often where commercial validation is years away — and the depth of the Scientific Advisory Board distinguish DFV from generalist firms operating across the same broad technology sectors.

Domain Capital Group, founded in 1985, specializes in biotechnology investments, managing a substantial $2.8 billion in assets. They have funded 194 companies in the biopharma, medical device, and diagnostic sectors, resulting in 90 IPOs and 110 M&A events. Notable companies in their portfolio include Zipline, GitLab, and DigitalOcean. Domain Capital’s strategy focuses on long-term partnerships and a diversified asset approach, investing in real estate, natural resources, media, entertainment, technology, and special situations to achieve stable, cash-on-cash returns. They operate globally with a team led by seasoned partners like James Blair and Brian Halak. Their investment process involves rigorous due diligence, strategic transaction structuring, and active asset management to ensure value creation and capital preservation. Domain Capital typically engages in growth and late-stage investments, leveraging their extensive industry experience and strong relationships to source and manage deals effectively. The firm’s hands-on approach includes personalized investor engagement, aiming to meet specific investment goals such as targeted returns and risk mitigation. This comprehensive strategy positions Domain Capital as a trusted partner for public and private pension plans, corporations, foundations, endowments, and high-net-worth individuals.

Donovan Capital Group, headquartered in Tysons Corner, Virginia, specializes in providing non-control structured equity and mezzanine debt investments in the aerospace, defense, and government services sectors. Founded in 2019, Donovan Capital is a family office with $300 million in pledged capital, allowing them to pursue flexible, long-term investment opportunities. Their investment approach includes equity co-investments, various forms of debt financing, and special situation lending, typically targeting U.S.-based companies with revenues between $10 million and $100 million and EBITDA of at least $3 million. Notable investments and partnerships include their strategic alliance with Boone Group, a federal acquisition firm, which enhances their ability to deploy advanced technology tools and information to the U.S. Department of Defense and Intelligence Community. This partnership exemplifies Donovan Capital's commitment to supporting businesses that provide mission-critical services and products to the government. The firm leverages a team with extensive backgrounds in government and defense, including former leaders from various U.S. federal agencies. This expertise allows Donovan Capital to understand the unique challenges and opportunities within the government contracting space, offering tailored capital solutions to help companies grow and navigate this complex market​.

Doral Energy-Tech Ventures is the corporate venture capital arm of Doral Group, a leading global renewable energy company based in Israel. Founded in 2021, Doral Energy-Tech Ventures focuses on investing in early-stage companies that are developing innovative technologies in renewable energy and cleantech sectors, including solar and wind technologies, energy storage, smart grids, hydrogen, and water technologies. The fund supports startups by providing not just financial backing but also strategic guidance, access to Doral’s technological capabilities, and a vast network of opportunities to help them scale and succeed in the global market. Their portfolio includes companies like Yotta Energy, OxCCU, and Phinergy, which are making significant strides in areas like energy storage and hydrogen technology. Led by Roee Furman as Managing Director and Guy Yavin as Investment Director, Doral Energy-Tech Ventures emphasizes a collaborative approach, partnering closely with entrepreneurs to address global sustainability challenges and drive impactful innovations.

Dorm Room Fund (DRF), founded in 2012 by Josh Kopelman under the auspices of First Round Capital, is a venture capital firm that focuses on investing in student-run startups. Headquartered in Cambridge, Massachusetts, DRF has made over 400 investments and has achieved 145 exits. Notable exits include MetaMap, DiscreetAI, WorkerSense, and ScienceIO. DRF’s mission is to support student founders by providing access to a powerful investor network, world-class mentors, and essential capital to accelerate their growth. The fund has supported over 300 companies led by student founders, including prominent names like Athelas and WellTheory. Dorm Room Fund is dedicated to promoting diversity, equity, and inclusion within the venture capital industry. Nearly 80% of their alumni go on to become founders or venture capitalists themselves. The fund has created initiatives like the Blueprint Project and the Female Founder Track to empower underrepresented students. The investment team at DRF consists of student partners who bring unique insights into the next wave of groundbreaking companies. This model allows them to identify promising startups that might be overlooked by traditional investors.

Dragonfly Capital, founded in 2018, is a global venture capital firm with a strong focus on cryptocurrency and blockchain technology. With headquarters in San Francisco, Dragonfly has rapidly become a key player in the crypto space, supporting startups and projects that push the boundaries of decentralized finance (DeFi), blockchain infrastructure, and emerging consumer crypto products like NFTs and decentralized autonomous organizations (DAOs). The firm recently closed its third venture fund at $650 million, surpassing its initial target of $500 million. This new fund enables Dragonfly to invest across all stages of development, from seed funding to later-stage growth, helping build "generational companies" in crypto. Notable portfolio investments include projects like Aptos, Bybit, and Celo, which span sectors from layer-one blockchain protocols to NFT platforms. Led by managing partner Haseeb Qureshi, Dragonfly works closely with founders across the globe, combining deep technical expertise and market knowledge to help teams scale. Their global reach and focus on collaboration with the best crypto-native founders have positioned them as a leading venture fund in the rapidly evolving blockchain ecosystem​.

Drake Star Partners is a prominent global investment banking firm specializing in the technology sector. With a strong presence in major financial hubs including New York, London, Paris, Munich, and San Francisco, Drake Star provides strategic M&A and corporate finance advisory services. They have completed over 450 transactions since 2003, amounting to more than $22 billion in deal volume. The firm focuses on various sectors such as Software/SaaS, Digital Media, FinTech, Industrial Tech, Mobility & Sustainability, and Consumer & Retail Tech. They have been involved in significant deals, acting as exclusive financial advisors for companies like Symbioworld, Cognodata, and Game Circus​. Drake Star is known for its deep industry expertise and collaborative approach, providing tailored solutions to rapidly-scaling startups and large corporations. Their team of over 100 senior professionals leverages a vast network to deliver exceptional results across many transaction types, making them a leading international investment bank.

Draper Associates, founded in 1985 by Tim Draper, is a renowned early-stage venture capital firm based in Silicon Valley. The firm has made significant investments in transformative companies across various sectors, including technology, consumer services, and financial services. Draper Associates is known for its notable investments in companies like Hotmail, Skype, Tesla, SpaceX, Twitch, Robinhood, Coinbase, and Baidu. The firm focuses on backing innovative startups with the potential for extraordinary outcomes, often investing at the seed stage and supporting companies through their growth journeys. Draper Associates prides itself on being entrepreneur-friendly, providing extensive support and resources to help founders succeed. Draper Associates is part of the larger Draper Ecosystem, which includes Draper University, Draper Venture Network, and Draper Startup House, among other initiatives aimed at fostering entrepreneurial growth and innovation globally. The firm's investment philosophy emphasizes a global perspective, investing in industry-transforming companies across the world while maintaining a strong presence in Silicon Valley. Draper Associates continues to innovate and drive significant impact in the venture capital landscape by backing visionary entrepreneurs and leveraging its extensive network and resources.

Draper B1, founded in 2010 and headquartered in Valencia, Spain, is a venture capital firm focusing on seed and early-stage investments. They emphasize supporting ambitious founders aiming to create impactful businesses. Draper B1 has a diverse portfolio spanning B2B, B2C, software, marketplaces, artificial intelligence, blockchain, and mobile applications. Notable investments include companies like Signaturit, Streamloots, and Erudit AI. They have supported over 150 companies, providing more than just capital. Draper B1 prides itself on hands-on investment and active portfolio management, leveraging a global network to help startups scale internationally. They have had multiple successful exits, including companies such as Jeff and Civitfun. Their team, led by Managing Partners like Luz Adell and Enrique Penichet Garcia, focuses on local sourcing for global scaling, helping startups navigate both local and international markets effectively. Draper B1 is part of the Draper Venture Network, enhancing their ability to support their portfolio companies with a broad range of resources and connections.